{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:44:39Z","timestamp":1782182679109,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007181","name":"Quality Enhancement Research Initiative","doi-asserted-by":"publisher","award":["20-025"],"award-info":[{"award-number":["20-025"]}],"id":[{"id":"10.13039\/100007181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The combined use of antiplatelet medications with direct oral anticoagulants increases patients\u2019 risk of hemorrhage. In 2021, a multistate network of Veterans Affairs medical centers in the United States deployed a successful multicomponent stewardship initiative to reduce inappropriate anticoagulant-antiplatelet therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Identify barriers, facilitators, and potential adaptations of the initiative to guide broader dissemination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical pharmacists and pharmacist managers were invited to\u00a0participate in semi-structured interviews about their experiences with the initiative. Interviews were transcribed. Thematic analysis was informed by the Consolidated Framework for Implementation Research (CFIR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen interviews were completed (response rate 68%). The initiative was considered important and worth disseminating, and the addition of a visual alert to flag potential deprescribing candidates on an anticoagulation population management dashboard was considered especially beneficial. Three primary themes were identified using the CFIR. First, pharmacists often encountered barriers to coordination across specialties, with some clinicians unconvinced of the clinical evidence favoring antiplatelet deprescribing; breaking down these clinical silos, through targeted education and identifying meaningful clinician champions, is essential to increasing success of this initiative. Second, pharmacists sought clarification about how their deprescribing efforts, a relatively new activity, would be accounted for in performance evaluations, and how clinics would meet increased staffing needs. Third, adaptability of the initiative to local context was considered valuable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>As part of a multicomponent oral anticoagulant-antiplatelet stewardship initiative, preventing clinical silos, clarifying expectations around performance and staffing, and permitting adaptations to local context are important to maximizing impact.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-025-01922-2","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:17:58Z","timestamp":1749010678000},"page":"1710-1719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A qualitative evaluation of barriers and facilitators to a large-scale antithrombotic stewardship intervention in the United States Veterans Healthcare system"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1798-060X","authenticated-orcid":false,"given":"Jacob E.","family":"Kurlander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lacey","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Von","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison A.","family":"Ranusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"11","key":"1922_CR1","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3390\/jcm10112367","volume":"10","author":"L Zerah","year":"2021","unstructured":"Zerah L, Bonnet-Zamponi D, Ajrouche A, et al. Inappropriate use of oral antithrombotic combinations in an outpatient setting and associated risks: a French nationwide cohort study. J Clin Med. 2021;10(11):2367. https:\/\/doi.org\/10.3390\/jcm10112367.","journal-title":"J Clin Med"},{"issue":"4","key":"1922_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamainternmed.2018.7816","volume":"179","author":"JK Schaefer","year":"2019","unstructured":"Schaefer JK, Li Y, Gu X, et al. Association of adding aspirin to warfarin therapy without an apparent indication with bleeding and other adverse events. JAMA Intern Med. 2019;179(4):533\u201341. https:\/\/doi.org\/10.1001\/jamainternmed.2018.7816.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"1922_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamainternmed.2021.1197","volume":"181","author":"JK Schaefer","year":"2021","unstructured":"Schaefer JK, Errickson J, Li Y, et al. Adverse events associated with the addition of aspirin to direct oral anticoagulant therapy without a clear indication. JAMA Intern Med. 2021;181(6):817\u201324. https:\/\/doi.org\/10.1001\/jamainternmed.2021.1197.","journal-title":"JAMA Intern Med"},{"issue":"20","key":"1922_CR4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1136\/heartjnl-2014-305486","volume":"100","author":"R De Caterina","year":"2014","unstructured":"De Caterina R, Ammentorp B, Darius H, et al. Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. Heart. 2014;100(20):1625\u201335. https:\/\/doi.org\/10.1136\/heartjnl-2014-305486.","journal-title":"Heart"},{"issue":"21","key":"1922_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.020907","volume":"10","author":"Y Matsuzawa","year":"2021","unstructured":"Matsuzawa Y, Kimura K, Yasuda S, et al. Antithrombotic therapy for atrial fibrillation and coronary artery disease in patients with prior atherothrombotic disease: a post hoc analysis of the AFIRE trial. J Am Heart Assoc. 2021;10(21): e020907. https:\/\/doi.org\/10.1161\/JAHA.121.020907.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"1922_CR6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.110.973008","volume":"123","author":"LA Garc\u00eda Rodr\u00edguez","year":"2011","unstructured":"Garc\u00eda Rodr\u00edguez LA, Lin KJ, Hern\u00e1ndez-D\u00edaz S, et al. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation. 2011;123(10):1108\u201315. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.973008.","journal-title":"Circulation"},{"issue":"16","key":"1922_CR7","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","volume":"170","author":"ML Hansen","year":"2010","unstructured":"Hansen ML, S\u00f8rensen R, Clausen MT, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med. 2010;170(16):1433\u201341. https:\/\/doi.org\/10.1001\/archinternmed.2010.271.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1922_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"DJ Kumbhani","year":"2021","unstructured":"Kumbhani DJ, Cannon CP, Beavers CJ, et al. 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2021;77(5):629\u201358. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.011.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1922_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"issue":"1","key":"1922_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41514-023-00132-2","volume":"10","author":"M Robinson","year":"2024","unstructured":"Robinson M, Mokrzecki S, Mallett AJ. Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review. Npj Aging. 2024;10(1):1\u20136. https:\/\/doi.org\/10.1038\/s41514-023-00132-2.","journal-title":"Npj Aging"},{"issue":"2","key":"1922_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/ijpp\/riad001","volume":"31","author":"DA Okeowo","year":"2023","unstructured":"Okeowo DA, Zaidi STR, Fylan B, et al. Barriers and facilitators of implementing proactive deprescribing within primary care: a systematic review. Int J Pharm Pract. 2023;31(2):126\u201352. https:\/\/doi.org\/10.1093\/ijpp\/riad001.","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"1922_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11096-021-01336-w","volume":"44","author":"B Tangiisuran","year":"2022","unstructured":"Tangiisuran B, Rajendran V, Shaaban A, et al. Physicians, perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study. Int J Clin Pharm. 2022;44(1):201\u201313. https:\/\/doi.org\/10.1007\/s11096-021-01336-w.","journal-title":"Int J Clin Pharmacy."},{"issue":"4","key":"1922_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s11239-022-02669-7","volume":"54","author":"JK Schaefer","year":"2022","unstructured":"Schaefer JK, Barnes GD, Sussman JB, et al. A survey of internists, recommendations for aspirin in older adults and barriers to evidence-based use. J Thromb Thrombolysis. 2022;54(4):639\u201346. https:\/\/doi.org\/10.1007\/s11239-022-02669-7.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"1922_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102421","volume":"8","author":"JE Kurlander","year":"2024","unstructured":"Kurlander JE, Helminski D, Yuan L, et al. Feasibility and acceptability of patient- and clinician-level antithrombotic stewardship interventions to reduce gastrointestinal bleeding risk in patients using warfarin (Anticoagulation with Enhanced Gastrointestinal Safety): a factorial randomized controlled pilot trial. Res Pract Thromb Haemost. 2024;8(4): 102421. https:\/\/doi.org\/10.1016\/j.rpth.2024.102421.","journal-title":"Res Pract Thromb Haemost"},{"key":"1922_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.11.024","author":"JE May","year":"2024","unstructured":"May JE, Allen AL, Bannow BT, et al. Safe and effective anticoagulation use: case studies in anticoagulation stewardship. J Thrombosis Haemostasis. 2024. https:\/\/doi.org\/10.1016\/j.jtha.2024.11.024.","journal-title":"J Thrombosis Haemostasis"},{"issue":"5","key":"1922_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12757","volume":"6","author":"AE Burnett","year":"2022","unstructured":"Burnett AE, Barnes GD. A call to action for anticoagulation stewardship. Res Pract Thromb Haemost. 2022;6(5): e12757. https:\/\/doi.org\/10.1002\/rth2.12757.","journal-title":"Res Pract Thromb Haemost"},{"issue":"24","key":"1922_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022758","volume":"10","author":"AL Allen","year":"2021","unstructured":"Allen AL, Lucas J, Parra D, et al. Shifting the paradigm: a population health approach to the management of direct oral anticoagulants. J Am Heart Assoc. 2021;10(24): e022758. https:\/\/doi.org\/10.1161\/JAHA.121.022758.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1922_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.122.009256","volume":"16","author":"MP Dorsch","year":"2023","unstructured":"Dorsch MP, Chen CS, Allen AL, et al. Nationwide implementation of a population management dashboard for monitoring direct oral anticoagulants: insights from the veterans affairs health system. Circ Cardiovasc Qual Outcomes. 2023;16(2): e009256. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.122.009256.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"1922_CR19","doi-asserted-by":"publisher","DOI":"10.2196\/49025","volume":"10","author":"A Ranusch","year":"2023","unstructured":"Ranusch A, Lin YJ, Dorsch MP, et al. Role of individual clinician authority in the implementation of informatics tools for population-based medication management: qualitative semistructured interview study. JMIR Hum Factors. 2023;10(1): e49025. https:\/\/doi.org\/10.2196\/49025.","journal-title":"JMIR Hum Factors"},{"key":"1922_CR20","unstructured":"Goldmann D, Williams D, Berwick D. Practical Improvement Science in Health Care: A Roadmap for Getting Results [Online course]. Harvard University. https:\/\/pll.harvard.edu\/course\/ph556x-practical-improvement-science-health-care-roadmap-getting-results."},{"key":"1922_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-69909-7_3470-2","volume-title":"Thematic Analysis: A Practical Guide","author":"V Braun","year":"2022","unstructured":"Braun V, Clarke V. Thematic Analysis: A Practical Guide. UK: Sage; 2022."},{"issue":"1","key":"1922_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, et al. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022;17(1):75. https:\/\/doi.org\/10.1186\/s13012-022-01245-0.","journal-title":"Implement Sci"},{"issue":"3","key":"1922_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11096-023-01555-3","volume":"45","author":"A Al Rowily","year":"2023","unstructured":"Al Rowily A, Aloudah N, Jalal Z, et al. Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists, views and experiences. Int J Clin Pharm. 2023;45(3):681\u20138. https:\/\/doi.org\/10.1007\/s11096-023-01555-3.","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"1922_CR24","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/jac5.1842","volume":"6","author":"S Ou","year":"2023","unstructured":"Ou S, Pozzolano E, Datta A, et al. Aspirin deprescribing in patients on oral anticoagulation for atrial fibrillation or venous thromboembolism: a national survey of clinician practices. JACCP J Am Coll Clin Pharm. 2023;6(7):690\u2013700. https:\/\/doi.org\/10.1002\/jac5.1842.","journal-title":"JACCP J Am Coll Clin Pharm"},{"issue":"12","key":"1922_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061686","volume":"12","author":"L Brunner","year":"2022","unstructured":"Brunner L, Rodondi N, Aubert CE. Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review. BMJ Open. 2022;12(12): e061686. https:\/\/doi.org\/10.1136\/bmjopen-2022-061686.","journal-title":"BMJ Open"},{"issue":"2","key":"1922_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1468-0009.2012.00666.x","volume":"90","author":"SA Kreindler","year":"2012","unstructured":"Kreindler SA, Dowd DA, Dana Star N, et al. Silos and social identity: the social identity approach as a framework for understanding and overcoming divisions in health care. Milbank Q. 2012;90(2):347\u201374. https:\/\/doi.org\/10.1111\/j.1468-0009.2012.00666.x.","journal-title":"Milbank Q"},{"key":"1922_CR27","unstructured":"Oandasan I, Baker G, Barker K, et al. Teamwork in healthcare: promoting effective teamwork in healthcare in Canada. Can Health Serv Res Found. 2006. https:\/\/www.researchgate.net\/publication\/249940003. Accessed Feb 2025"},{"issue":"8","key":"1922_CR28","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.34172\/ijhpm.2022.7088","volume":"11","author":"G Harvey","year":"2022","unstructured":"Harvey G. Context matters, So How Do We Get better at working with context in implementation research and practice? Int J Health Policy Manag. 2022;11(8):1587\u20139. https:\/\/doi.org\/10.34172\/ijhpm.2022.7088.","journal-title":"Int J Health Policy Manag"},{"key":"1922_CR29","unstructured":"NHS. Pharmacy First. NHS England. 2024. https:\/\/www.england.nhs.uk\/primary-care\/pharmacy\/pharmacy-services\/pharmacy-first\/. Accessed 15 Mar 2025"},{"issue":"3","key":"1922_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/pharmacy8030140","volume":"8","author":"NL Bragazzi","year":"2020","unstructured":"Bragazzi NL, Mansour M, Bonsignore A, et al. The role of hospital and community pharmacists in the management of COVID-19: towards an expanded definition of the roles, responsibilities, and duties of the pharmacist. Pharmacy. 2020;8(3):140. https:\/\/doi.org\/10.3390\/pharmacy8030140.","journal-title":"Pharmacy"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-01922-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:07:46Z","timestamp":1763554066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-01922-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1922"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-01922-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JEK has received speaker fees from the Anticoagulation Forum. GDB has received Grant Funding\u2014Boston Scientific; Consulting fees\u2014Pfizer, Bristol-Myers Squibb, Janssen, Bayer, AstraZeneca, Sanofi, Anthos, Abbott Vascular, Boston Scientific; serves on the Board of Directors\u2014Anticoagulation Forum. All other authors have no competing interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}